Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
Public ClinicalTrials.gov record NCT02702271. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is a prospective, non-randomized, multi-center investigation to establish the safety and effectiveness of the WATCHMAN FLX™ Left Atrial Appendage Closure Device for subjects with non-valvular atrial fibrillation who are eligible for long-term anti-coagulation therapy to reduce the risk of stroke but who have a rationale to seek a non-pharmacologic alternative.
Study identification
- NCT ID
- NCT02702271
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 458 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 6, 2018
- Primary completion
- Jan 27, 2020
- Completion
- Mar 11, 2021
- Last update posted
- Jun 13, 2022
2018 – 2021
United States locations
- U.S. sites
- 29
- U.S. states
- 22
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Grandview Medical Center | Birmingham | Alabama | 35243 | — |
| Phoenix Cardiovascular Research Group | Phoenix | Arizona | 85006 | — |
| St. Joseph's Hospital & Medical Center | Phoenix | Arizona | 85016 | — |
| Nair Research, LLC | Jonesboro | Arkansas | 72401 | — |
| Scripps Green | La Jolla | California | 92037 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Sharpe Chula Vista Medical Center | San Diego | California | 92121 | — |
| St. John's Hospital / Pacific Heart | Santa Monica | California | 90404 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Tallahassee Memorial Hospital | Tallahassee | Florida | 32308 | — |
| Emory University | Atlanta | Georgia | 30308 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Mayo Clinic | Rochester | Minnesota | 55902 | — |
| HealthEast St. Joseph's Hospital | Saint Paul | Minnesota | 55102 | — |
| Cardiology Associates of N. Mississippi | Tupelo | Mississippi | 38801 | — |
| St. Luke's Hospital | Kansas City | Missouri | 64111 | — |
| Catholic Medical Center | Manchester | New Hampshire | 03102 | — |
| Cardiovascular Associates of the Delaware Valley | Sewell | New Jersey | 08080 | — |
| New York University Medical Center | New York | New York | 10016 | — |
| Mt. Sinai School of Medicine | New York | New York | 10029 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Legacy Emanuel Hospital & Health Center | Portland | Oregon | 97227 | — |
| York Hospital | York | Pennsylvania | 17403 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Texas Cardiac Arrhythmia | Austin | Texas | 78705 | — |
| Sentara Norfolk General Hospital | Norfolk | Virginia | 23507 | — |
| Virginia Commonwealth University Health System | Richmond | Virginia | 23219 | — |
| PeaceHealth Southwest Medical | Vancouver | Washington | 98664 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Atrial Fibrillation trials
Other public records listing Atrial Fibrillation. Sorted by last update posted; newest first. Not a recommendation.
- NCT06716021: ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 Not yet recruiting
- NCT07081711: Longitudinal Validation of CIRC Technologies Recruiting
- NCT07625215: A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation Not yet recruiting
- NCT06099730: Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF Recruiting
- NCT07275151: Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA Recruiting
- NCT04685317: Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02702271, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2022 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02702271 live on ClinicalTrials.gov.